WARNER'S CORNER

The Economic Impact of Elective Orthopedic Surgery

Dear CSS Members and Colleagues: Enclosed is a very informative study form the Johns Hopkins shoulder team which considers the impact of orthopedic surgery on the bottom line of our hospitals’ revenue. This fits very well with the Video programs we have already posted on VuMedi on Orthopedic Business post-pandemic (https://www.vumedi.com/channel/codman-shoulder-society/). The conclusions are as follows: “Elective MSK surgery accounted for $65.6–$71.1 billion in reimbursement and $15.6–$21.1 billion in net income per year to the US hospital system, equivalent to $5.5–$5.9 billion in reimbursement and $1.3–$1.8 billion in net income per month. When compared with elective surgery from all other

Post-Pandemic Challenges and Opportunities in Orthopedics-Part 2a and 2b

Dear CSS Members and Colleagues: I wanted to make you aware that we have completed and posted our pre-recorded webinar on “Post-Pandemic Challenges and Opportunities in Orthopedics- Part 2a and 2b”. You may remember, I invited all of you to offer questions for our panel on topics related to aspects of the “new normal” for Orthopedic care. This Webinar addresses these questions. The webinar is organized into two parts. Part 2a is split into 7 separate videos so as to allow for easy viewing in segments, as the overall program is probably too extensive for a single viewing. Here are the individual talks: -The Road Ahead -Orthopedic Group Practice Opportunity vs. Reality -How Surgeons, Hospitals